Utility of the PROSTest, a novel blood-based molecular assay, versus PSA for prostate cancer stratification and detection of higher grade disease. Insight into the global mortality trends due to ...

The treatment of metastatic castration-resistant prostate cancer (mCRPC) involves a combination of therapies, including chemotherapy, hormone therapy, immunotherapy, and different medications that ...

Vipul R. Patel, MD, FACS, is a board-certified urologic surgeon, medical director of the Global Robotics Institute at AdventHealth, and medical director of urologic oncology at AdventHealth Cancer ...

Steam may be more powerful than you think. It smooths clothes and kills germs, but now doctors are testing it against cancer. At Keck Medicine of USC, part of a large nationwide study, researchers are ...

Men who undergo prostate cancer treatment face a greatly increased risk of life-altering, long-term complications, a new study finds. Surgery for prostate cancers increases a man's risk of urinary or ...

Prostate cancer treatments lead to higher long-term complication rates, emphasizing the need for informed decision-making regarding treatment options and side effects. Prostatectomy patients ...

What if a medicine you thought of as “old news” suddenly showed up in new research with fresh benefits that might stretch ...

Angela Jia, MD, PhD, is a radiation oncologist specializing in stereotactic body radiation therapy (SBRT), adaptive radiotherapy, and clinical trials focused on prostate, bladder, and kidney cancers.

Feb 12 (Reuters) - When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the skin may be just as effective as traditional means of ...

Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer.